TA
ADMA icon

Teachers Advisors’s ADMA Biologics ADMA Stock Holding History

Teachers Advisors’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$87K Hold
23,078
– – ﹤0.01% 2946
2018
Q4 		$55K Hold
23,078
– – ﹤0.01% 2983
2018
Q3 		$143K Hold
23,078
– – ﹤0.01% 2987
2018
Q2 		$104K Buy
+23,078
New +$115K ﹤0.01% 3042

Other funds holding ADMA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
MWVC
Morgens Waterfall Vintiadis & Co New York $81.2M AUM 86.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Teachers Advisors's ADMA Position: Q1 2019 in Review

Teachers Advisors held its ADMA Biologics (ADMA) position steady in Q1 2019 at 23,078 shares worth $87K. The position accounts for ﹤0.01% of the portfolio, ranked #2946.

Teachers Advisors first reported a position in ADMA in Q2 2018 and has held it in 4 quarters since. The position peaked at $143K in Q3 2018. 56 funds tracked by Wall St. Rank hold ADMA as of Q1 2019.

  • Teachers Advisors held 23,078 shares of ADMA Biologics worth $87K as of Q1 2019.
  • Teachers Advisors left its ADMA Biologics share count unchanged in Q1 2019.
  • ADMA Biologics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2946 holding.
  • Teachers Advisors first reported a position in ADMA Biologics in Q2 2018 and has held it in 4 quarters since.
  • Teachers Advisors's ADMA Biologics position peaked at $143K in Q3 2018.
  • 56 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.